Publications by authors named "Martin Svaton"

Claim this Profile
I
Impact of Baseline Body Mass Index on Immunotherapy Outcomes in Patients With Non-small-cell Lung Cancer.
Daniel Krejčí, Adam Šubrt, Petr Opálka, Jana Krejčí, Monika Šibalová

Anticancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of lung cancer in pregnant women.
Martin Svaton

Curr Opin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the efficacy of cisplatin and carboplatin in combination with etoposide in firstline treatment of extensive-stage small cell lung cancer in real-world practice in the Czech Republic - a retrospective analysis of patients from the LUCAS project.
Alzbeta Bejckova, Miloslav Marel, Zdenka Chladkova, Libor Fila, Luis Fernando Casas-Mendez, Martin Svaton

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab versus Pembrolizumab plus Chemotherapy in Non-small Cell Lung Cancer with High PD-L1 Expression - Multicenter Real-world Evidence Study.
Martin Svaton, Magdalena Knetki-Wroblewska, Petr Hosek, Gabriela Chowaniecova, Jan Spacek

J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of second- and third-line chemotherapy after chemotherapy with platinum doublet and immunotherapy in non-small cell lung cancer: a descriptive study.
Martin Svaton, Miloslav Marel, Ondrej Venclicek, Juraj Kultan, Marketa Cernovska

Transl Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous transthoracic needle biopsy of lung lesions is a safe method associated with a very low risk of pleural recurrence.
Martin Svaton, David Havel, Marcela Buresova, Jan Baxa, Petr Hosek

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of PD-L1 Expression on the Overall Survival of Patients With Non-small Cell Lung Cancer Treated With Single-agent Pembrolizumab.
Martin Svaton, Magdalena Knetki-Wroblewska, Sylwia Tabor, Petr Domecky, Ondrej Venclicek

In Vivo· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omission of staging PET/CT linked to reduced survival in stage III non-small cell lung cancer: insights from the LUCAS project real-world data.
Gabriela Krakorova, Petr Domecky, Jiri Blazek, Milos Pesek, Ondrej Venclicek, Martin Svaton

Transl Lung Cancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of first-line anticancer treatment may predict treatment response in further lines in stage III/IV patients with non-small cell lung cancer.
Monika Bratova, Jana Skrickova, Magda Matusikova, Karolina Hrabcova, Libor Havel, Martin Svaton

J Cancer Res Clin Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer.
Jiri Blazek, Petr Hosek, Karolina Hrabcova, Monika Bratova, Juraj Kultan, Martin Svaton

In Vivo· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma.
Vlastimil Kulda, Jiri Polivka, Martin Svaton, Tomas Vanecek, Marcela Buresova

Cancer Genomics Proteomics· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative Plasma miRNA Levels Predict Prognosis in Early-stage Malignant Melanoma.
Mahyar Sharif Bagheri, Jiri Polivka, Inka Treskova, Katerina Houfkova, Tereza Knizkova, Martin Svaton

Anticancer Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA correlates with Lactate Dehydrogenase, CYFRA 21-1, and CRP levels in patients with advanced NSCLC.
Marcela Buresova, Lucie Benesova, Marek Minarik, Renata Ptackova, Tereza Halkova, Martin Svaton

J Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Cancer Versus "Young Cancer": Is Non-Small Cell Lung Cancer in Young Patients a Different Entity?
Monika Bratova, Kristian Brat, Karolina Hurdalkova, Magda Barinova, Marie Drosslerova, Martin Svaton

J Adolesc Young Adult Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Neo/adjuvant immunotherapy in the treatment of nonsmall cell lung cancer].
Martin Svatoň, Jiří Blažek, Marcela Burešová, Josef Vodička

Vnitr Lek· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer.
Martin Svaton, Marie Drosslerova, Ondrej Fischer, Miloslav Marel, Michal Hrnciarik

Transl Cancer Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection and Quantification of ctDNA for Longitudinal Monitoring of Treatment in Non-Small Cell Lung Cancer Patients Using a Universal Mutant Detection Assay by Denaturing Capillary Electrophoresis.
Lucie Benesova, Renata Ptackova, Tereza Halkova, Anastasiya Semyakina, Martin Svaton

Pathol Oncol Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer.
Martin Pesta, Dattatrya Shetti, Vlastimil Kulda, Tereza Knizkova, Katerina Houfkova, Martin Svaton

Diagnostics (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Mediastinitis - Outcomes and Prognostic Factors of Surgical Therapy (A Single-Center Experience).
Josef Vodička, Jan Geiger, Alexandra Židková, Pavel Andrle, Hynek Mírka, Martin Svatonˇ

Ann Thorac Cardiovasc Surg· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Previous Chemotherapy Affect the Outcome of Nivolumab Treatment in Non-small Cell Lung Cancer?
Martin Svaton, Monika Bratova, Leona Koubkova, Ondrej Fischer, Bohuslav Melichar

Anticancer Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Circulating Tumour DNA and F-FDG PET/CT for Precision Monitoring of Therapy Response in Patients With Advanced Non-small Cell Lung Cancer: A Prospective Study.
Ondrej Fiala, Jan Baxa, Martin Svaton, Lucie Benesova, Renata Ptackova

Cancer Genomics Proteomics· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory Parameters Associated With Inflammation Do Not Affect PD-L1 Expression in Non-small Cell Lung Cancer.
Martin Svaton, Marie Drosslerova, Ondrej Fischer, Miloslav Marel, Michal Hrnciarik

Anticancer Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worse Prognosis in the Symptomatic Patients With Lung Cancer - Czech Multicentric Study.
Miloslav Marel, Zdenka Chladkova, Luis Fernando Casas Mendez, Ondrej Venclicek, Jana Skrickova, Martin Svaton

Cancer Diagn Progn· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry.
Ondrej Venclicek, Jana Skrickova, Kristian Brat, Ondrej Fischer, Libor Havel, Martin Svaton

Anticancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Exon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer.
Jana Skrickova, Milos Pesek, Petr Opalka, Leona Koubkova, Milada Zemanova, Martin Svaton

Anticancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis